Luke Wittenburg

Assistant Professor

Surgical & Radiological Sciences

218 CCAH, Davis, CA 95616

Colorado Veterinarian License
California University Veterinarian License
1999, BS, New Mexico State University, Las Cruces, NM
2004, DVM, Colorado State University, Fort Collins, CO
2010, PhD, Colorado State University, Fort Collins, CO
2013, DACVCP, Colorado State University, Fort Collins, CO
2017, Certificate of Completion, University Of California, Davis, Davis, CA
Active Research Grants
Principal Investigator, Defining the role of core binding factor protein interactions in osteosarcoma, (Principal Investigator), NIH Office of Research Infrastructure Programs (ORIP)
Collaborator, Dysregulation of FSH in obesity: Functional and Statistical Analysis, Alex J. Polotsky (Principal Investigator), Eunice Kennedy Shriver National Institute of Child Health & Human Development
Principal Investigator, Safety and tolerability of a systemic doxorubicin prodrug with local hydrogel activation, (Principal Investigator), Shasqi, Inc
Co-Investigator, Developing a safe and effective anticoronaviral therapy for cats with FIP (continuation) , Brian Murphy/Niels Pedersen (Principal Investigator), Winn Feline Foundation
Principal Investigator, Pharmacokinetic analysis of vinblastine in tumor bearing cats and analysis of population covariates, (Principal Investigator), UC Davis Center for Companion Animal Health
Principal Investigator, Pilot pharmacokinetic evaluation of fractionated oral cyclophosphamide ind dogs with cancer, (Principal Investigator), CCAH
Co-Principal Investigator, Mechanism of pro-tumorigenic glioma-associated microglia: characterization of the role of olfactomedin-like 3, Christine Toedebusch (Principal Investigator), UCD Comprehensive Cancer Center Comparative Oncology Program
Co-Principal Investigator, Enhanced tumor permeation and retention of a nanoformulation of doxorubicin, Jenna Burton (Principal Investigator), Center for Companion Animal Health
Co-Investigator, Investigation of the Pharmacokinetics of Gabapentin Sedation in Cats with and without Chronic Kidney Disease, Jessica Quimby (Principal Investigator), Winn Feline Foundation
Most Recent Five Book Chapters
2018 Wittenburg LA, Gustafson DL : Chemotherapy of Neoplastic Diseases, Riviere JE, Papich MG, (ed), Veterinary Pharmacology and Therapeutics, Hoboken, NJ. 1191-1225.
Research Focus
Developmental Cancer Therapeutics